Immunocompromised patients have been neglected in COVID-19 trials: a call for action

Detalhes bibliográficos
Autor(a) principal: Trøseid, Marius
Data de Publicação: 2022
Outros Autores: Hentzien, Maxime, Ader, Florence, Cardoso, Sandra Wagner, Arribas, Jose R., Molina, Jean-Michel, Mueller, Nicolas, Hites, Maya, Bonnet, Fabrice, Manuel, Oriol, Costagliola, Dominique, Grinsztejn, Beatriz, Olsen, Inge Christoffer, Yazdapanah, Yazdan, Calmy, Alexandra
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da FIOCRUZ (ARCA)
Texto Completo: https://www.arca.fiocruz.br/handle/icict/53896
Resumo: Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
id CRUZ_5367ee2c8cf0b6d2b69603ea079d5144
oai_identifier_str oai:www.arca.fiocruz.br:icict/53896
network_acronym_str CRUZ
network_name_str Repositório Institucional da FIOCRUZ (ARCA)
repository_id_str 2135
spelling Trøseid, MariusHentzien, MaximeAder, FlorenceCardoso, Sandra WagnerArribas, Jose R.Molina, Jean-MichelMueller, NicolasHites, MayaBonnet, FabriceManuel, OriolCostagliola, DominiqueGrinsztejn, BeatrizOlsen, Inge ChristofferYazdapanah, YazdanCalmy, Alexandra2022-07-21T10:50:02Z2022-07-21T10:50:02Z2022TRØSEID, Marius et al. Immunocompromised patients have been neglected in COVID-19 trials: a call for action. Clinical Microbiology and Infection, n. 22, p. 1-3, 2022.1469-0691https://www.arca.fiocruz.br/handle/icict/5389610.1016/j.cmi.2022.05.005Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.Oslo University Hospital. Section of Clinical Immunology and Infectious Diseases. Oslo, Norway.Geneva University Hospitals. HIV/AIDS Research Unit. Geneva, Switzerland.Hospices Civils de Lyon. Hôpital de la Croix-Rousse. Département des Maladies Infectieuses et Tropicales. Lyon, France.Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil.Hospital La Paz. Infectious Diseases Unit. Madrid, Spain.Saint-Louis APHP. Infectious Diseases Department. Paris, France.University Hospital. Division of Infectious Diseases. Zurich, Switzerland.Université Libre de Bruxelles. Cliniques Universitaires de Bruxelles-Hôpital Érasme. Clinique des Maladies Infectieuses. Brussels, Belgium.CHU de Bordeaux and Université de Bordeaux. Bordeaux, France.Lausanne University Hospital. Infectious Diseases Service. Lausanne, Switzerland.Sorbonne Université. Institut Pierre Louis d'Epidémiologie et de Santé Publique. Paris, France.Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil.Oslo University Hospital. Dept. of Research Support for Clinical Trials. Oslo, Norway.Université de Paris. Paris, France.Geneva University Hospitals. HIV/AIDS Research Unit. Geneva, Switzerland.Although several innovative and repurposed drugs have been approved for the treatment of COVID-19 during the last year, we still do not have evidence-based knowledge on the best therapeutic strategy to treat immunocompromised patients. Most treatment guidelines are structured to whether the disease state is mild, moderate, or severe, and not sufficiently according to host factors including host immunity. Whereas the Omicron variant causes less severe diseases in the general population, this is not necessarily the case for individuals with an impaired immune system, such as organ transplant recipients, patients with hematological malignancies, active cancer or primary immunodeficiency, or individuals treated with immunosuppressive drugs for a variety of medical conditions.engElsevierhttps://www.arca.fiocruz.br/handle/icict/55854Immunocompromised patients have been neglected in COVID-19 trials: a call for actioninfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleAntiviralsCOVID-19GuidelinesImmunocompromisedTrialsinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-83099https://www.arca.fiocruz.br/bitstream/icict/53896/1/license.txt586c046dcfeef936e32f0323bb9a47c0MD51ORIGINALImmunocompromised_Beatriz_Grinsztejn_etal_INI_2022.pdfImmunocompromised_Beatriz_Grinsztejn_etal_INI_2022.pdfapplication/pdf276240https://www.arca.fiocruz.br/bitstream/icict/53896/2/Immunocompromised_Beatriz_Grinsztejn_etal_INI_2022.pdfde219db47dfe9ba9e3c0aa3ef4ce0d34MD52icict/538962023-07-13 21:06:48.409oai:www.arca.fiocruz.br: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ório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352023-07-14T00:06:48Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.pt_BR.fl_str_mv Immunocompromised patients have been neglected in COVID-19 trials: a call for action
title Immunocompromised patients have been neglected in COVID-19 trials: a call for action
spellingShingle Immunocompromised patients have been neglected in COVID-19 trials: a call for action
Trøseid, Marius
Antivirals
COVID-19
Guidelines
Immunocompromised
Trials
title_short Immunocompromised patients have been neglected in COVID-19 trials: a call for action
title_full Immunocompromised patients have been neglected in COVID-19 trials: a call for action
title_fullStr Immunocompromised patients have been neglected in COVID-19 trials: a call for action
title_full_unstemmed Immunocompromised patients have been neglected in COVID-19 trials: a call for action
title_sort Immunocompromised patients have been neglected in COVID-19 trials: a call for action
author Trøseid, Marius
author_facet Trøseid, Marius
Hentzien, Maxime
Ader, Florence
Cardoso, Sandra Wagner
Arribas, Jose R.
Molina, Jean-Michel
Mueller, Nicolas
Hites, Maya
Bonnet, Fabrice
Manuel, Oriol
Costagliola, Dominique
Grinsztejn, Beatriz
Olsen, Inge Christoffer
Yazdapanah, Yazdan
Calmy, Alexandra
author_role author
author2 Hentzien, Maxime
Ader, Florence
Cardoso, Sandra Wagner
Arribas, Jose R.
Molina, Jean-Michel
Mueller, Nicolas
Hites, Maya
Bonnet, Fabrice
Manuel, Oriol
Costagliola, Dominique
Grinsztejn, Beatriz
Olsen, Inge Christoffer
Yazdapanah, Yazdan
Calmy, Alexandra
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Trøseid, Marius
Hentzien, Maxime
Ader, Florence
Cardoso, Sandra Wagner
Arribas, Jose R.
Molina, Jean-Michel
Mueller, Nicolas
Hites, Maya
Bonnet, Fabrice
Manuel, Oriol
Costagliola, Dominique
Grinsztejn, Beatriz
Olsen, Inge Christoffer
Yazdapanah, Yazdan
Calmy, Alexandra
dc.subject.en.pt_BR.fl_str_mv Antivirals
COVID-19
Guidelines
Immunocompromised
Trials
topic Antivirals
COVID-19
Guidelines
Immunocompromised
Trials
description Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
publishDate 2022
dc.date.accessioned.fl_str_mv 2022-07-21T10:50:02Z
dc.date.available.fl_str_mv 2022-07-21T10:50:02Z
dc.date.issued.fl_str_mv 2022
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv TRØSEID, Marius et al. Immunocompromised patients have been neglected in COVID-19 trials: a call for action. Clinical Microbiology and Infection, n. 22, p. 1-3, 2022.
dc.identifier.uri.fl_str_mv https://www.arca.fiocruz.br/handle/icict/53896
dc.identifier.issn.pt_BR.fl_str_mv 1469-0691
dc.identifier.doi.none.fl_str_mv 10.1016/j.cmi.2022.05.005
identifier_str_mv TRØSEID, Marius et al. Immunocompromised patients have been neglected in COVID-19 trials: a call for action. Clinical Microbiology and Infection, n. 22, p. 1-3, 2022.
1469-0691
10.1016/j.cmi.2022.05.005
url https://www.arca.fiocruz.br/handle/icict/53896
dc.language.iso.fl_str_mv eng
language eng
dc.relation.hasversion.none.fl_str_mv https://www.arca.fiocruz.br/handle/icict/55854
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Elsevier
publisher.none.fl_str_mv Elsevier
dc.source.none.fl_str_mv reponame:Repositório Institucional da FIOCRUZ (ARCA)
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Repositório Institucional da FIOCRUZ (ARCA)
collection Repositório Institucional da FIOCRUZ (ARCA)
bitstream.url.fl_str_mv https://www.arca.fiocruz.br/bitstream/icict/53896/1/license.txt
https://www.arca.fiocruz.br/bitstream/icict/53896/2/Immunocompromised_Beatriz_Grinsztejn_etal_INI_2022.pdf
bitstream.checksum.fl_str_mv 586c046dcfeef936e32f0323bb9a47c0
de219db47dfe9ba9e3c0aa3ef4ce0d34
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv repositorio.arca@fiocruz.br
_version_ 1813008853559672832

Registros relacionados